Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Calamos International Growth C CIGCX
- NAV / 1-Day Return 17.43 / +0.98 %
- Total Assets 235.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.950%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield —
- Turnover 131%
USD | NAV as of May 06, 2024 | 1-Day Return as of May 06, 2024, 10:13 PM GMT+0
Morningstar’s Analysis CIGCX
Will CIGCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 33.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 6.10 | 14.7 Mil | Healthcare |
Advantest Corp | 4.11 | 9.9 Mil | Technology |
ASML Holding NV | 3.96 | 9.5 Mil | Technology |
Rolls-Royce Holdings PLC | 3.59 | 8.6 Mil | Industrials |
Taiwan Semiconductor Manufacturing Co Ltd | 2.97 | 7.1 Mil | Technology |
Hitachi Ltd | 2.93 | 7.1 Mil | Industrials |
SAP SE | 2.61 | 6.3 Mil | Technology |
Constellation Software Inc | 2.57 | 6.2 Mil | Technology |
Munters Group AB Class B | 2.28 | 5.5 Mil | Industrials |
MakeMyTrip Ltd | 2.28 | 5.5 Mil | Consumer Cyclical |